NCT00965289View on ClinicalTrials.gov

High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

June 30, 2009

Conditions
B-Cell Lymphoma
Interventions
DRUG

Rituximab

Rituximab infusion on day 1 dose: 375mg/m²

Trial Locations (1)

44000

University Hospital, Nantes

All Listed Sponsors
collaborator

French Innovative Leukemia Organisation

OTHER

collaborator

Hoffmann-La Roche

INDUSTRY

lead

Nantes University Hospital

OTHER

NCT00965289 - High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma | Biotech Hunter | Biotech Hunter